Entering text into the input field will update the search result below

Arcturus Therapeutics announces collaboration with CSL Seqirus

  • Arcturus Therapeutics (NASDAQ:ARCT) surges 32,4% after-hours on Tuesday after the firm enters a strategic collaboration with CSL Seqirus to provide former with a license to their self-amplifying mRNA technology to support the research, development, manufacture, and commercialization of vaccines for SARS-CoV-2, influenza, pandemic preparedness, as

Recommended For You

Related Stocks

SymbolLast Price% Chg
ARCT
--
CSLLY
--